{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:35:53Z","timestamp":1773675353627,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Exzellenzinitiative KIT"],"award-info":[{"award-number":["Exzellenzinitiative KIT"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Russian Scientific Fund","award":["14-23-00018"],"award-info":[{"award-number":["14-23-00018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00204-016-1754-3","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T16:20:54Z","timestamp":1466007654000},"page":"785-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells"],"prefix":"10.1007","volume":"91","author":[{"given":"Maria","family":"Cetraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasily","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolin","family":"Streule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery","family":"Golubev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1469-9150","authenticated-orcid":false,"given":"Beate","family":"K\u00f6berle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,15]]},"reference":[{"key":"1754_CR1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/js960037a","volume":"85","author":"A Andersson","year":"1996","unstructured":"Andersson A, Fagerberg J, Lewensohn R, Ehrsson H (1996) Pharmacokinetics of cisplatin and its monohydrated complex in humans. J Pharm Sci 85:824\u2013827","journal-title":"J Pharm Sci"},{"key":"1754_CR2","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/carcin\/21.11.2097","volume":"21","author":"M Asmuss","year":"2000","unstructured":"Asmuss M, Mullenders LH, Eker A, Hartwig A (2000) Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis 21:2097\u20132104","journal-title":"Carcinogenesis"},{"key":"1754_CR3","doi-asserted-by":"publisher","unstructured":"Basu A, Krishnamurthy S (2010) Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids. doi: 10.4061\/2010\/201367","DOI":"10.4061\/2010\/201367"},{"key":"1754_CR4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/carcin\/10.10.1905","volume":"10","author":"S Boiteux","year":"1989","unstructured":"Boiteux S, Bichara M, Fuchs RP, Laval J (1989) Excision of the imidazole ring-opened form of N-2-aminofluorene-C(8)-guanine adduct in poly(dG-dC) by Escherichia coli formamidopyrimidine-DNA glycosylase. Carcinogenesis 10:1905\u20131909","journal-title":"Carcinogenesis"},{"key":"1754_CR5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10495-007-0082-8","volume":"12","author":"P Bragado","year":"2007","unstructured":"Bragado P, Armesilla A, Silva A, Porras A (2007) Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 12:1733\u20131742","journal-title":"Apoptosis"},{"key":"1754_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.007","volume":"251","author":"A Brozovic","year":"2007","unstructured":"Brozovic A, Osmak M (2007) Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 251:1\u201316","journal-title":"Cancer Lett"},{"key":"1754_CR7","doi-asserted-by":"crossref","first-page":"a012599","DOI":"10.1101\/cshperspect.a012559","volume":"5","author":"J Cadet","year":"2013","unstructured":"Cadet J, Wagner JR (2013) DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harb Perspect Biol 5:a012599","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1754_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378","journal-title":"Eur J Pharmacol"},{"key":"1754_CR9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/0045-6535(83)90076-0","volume":"12","author":"C Eadsforth","year":"1983","unstructured":"Eadsforth C, Moser P (1983) Assessment of reverse-phase chromatographic methods for determining partition coefficients. Chemosphere 12:1459\u20131475","journal-title":"Chemosphere"},{"key":"1754_CR10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/ic00109a004","volume":"34","author":"CM Giandomenico","year":"1995","unstructured":"Giandomenico CM et al (1995) Carboxylation of kinetically inert platinum(IV) hydroxy complexes. An entr\u00e9e into orally active platinum(IV) antitumor agents. Inorg Chem 34:1015\u20131021","journal-title":"Inorg Chem"},{"key":"1754_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.48.080907.180426","volume":"48","author":"MD Hall","year":"2008","unstructured":"Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM (2008) The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48:495\u2013535","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1754_CR12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002800100363","volume":"48","author":"S Hector","year":"2001","unstructured":"Hector S, Bolanowska-Higdon W, Zdanowicz J, Hitt S, Pendyala L (2001) In vitro studies on the mechanisms of oxaliplatin resistance. Cancer Chemother Pharmacol 48:398\u2013406","journal-title":"Cancer Chemother Pharmacol"},{"key":"1754_CR13","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.162491399","volume":"99","author":"S Ishida","year":"2002","unstructured":"Ishida S, Lee J, Thiele DJ, Herskowitz I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99:14298\u201314302","journal-title":"Proc Natl Acad Sci USA"},{"key":"1754_CR14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","volume":"17","author":"S Ishida","year":"2010","unstructured":"Ishida S, McCormick F, Smith-McCune K, Hanahan D (2010) Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 17:574\u2013583","journal-title":"Cancer Cell"},{"key":"1754_CR15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1078-0432.CCR-08-2081","volume":"15","author":"DD Jandial","year":"2009","unstructured":"Jandial DD, Farshchi-Heydari S, Larson CA, Elliott GI, Wrasidlo WJ, Howell SB (2009) Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1. Clin Cancer Res 15:553\u2013560","journal-title":"Clin Cancer Res"},{"key":"1754_CR16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/13543784.16.7.1009","volume":"16","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin. Expert Opin Investig Drugs 16:1009\u20131021","journal-title":"Expert Opin Investig Drugs"},{"key":"1754_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5306\/wjco.v7.i1.106","volume":"7","author":"D Kilari","year":"2016","unstructured":"Kilari D, Guancial E, Kim ES (2016) Role of copper transporters in platinum resistance. World J Clin Oncol 7:106\u2013113","journal-title":"World J Clin Oncol"},{"key":"1754_CR18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0006-2952(96)00549-7","volume":"52","author":"B K\u00f6berle","year":"1996","unstructured":"K\u00f6berle B, Payne J, Grimaldi KA, Hartley JA, Masters JRW (1996) DNA-repair in cisplatin-sensitive and resistant human cell-lines measured in specific genes by quantitative polymerase chain-reaction. Biochem Pharmacol 52:1729\u20131734","journal-title":"Biochem Pharmacol"},{"key":"1754_CR19","first-page":"172","volume":"1806","author":"B K\u00f6berle","year":"2010","unstructured":"K\u00f6berle B, Tomicic MT, Usanova S, Kaina B (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 1806:172\u2013182","journal-title":"Biochim Biophys Acta"},{"key":"1754_CR20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","volume":"447","author":"H Koepsell","year":"2004","unstructured":"Koepsell H, Endou H (2004) The SLC22 drug transporter family. Pflugers Arch 447:666\u2013676","journal-title":"Pflugers Arch"},{"key":"1754_CR21","first-page":"1003","volume":"16","author":"H Koga","year":"2000","unstructured":"Koga H, Kotoh S, Nakashima M, Yokomizo A, Tanaka M, Naito S (2000) Accumulation of intracellular platinum is correlated with intrinsic cisplatin resistance in human bladder cancer cell lines. Int J Oncol 16:1003\u20131007","journal-title":"Int J Oncol"},{"key":"1754_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10555-007-9045-3","volume":"26","author":"MT Kuo","year":"2007","unstructured":"Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T (2007) The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 26:71\u201383","journal-title":"Cancer Metastasis Rev"},{"key":"1754_CR23","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1158\/0008-5472.CAN-12-0888","volume":"72","author":"MT Kuo","year":"2012","unstructured":"Kuo MT, Fu S, Savaraj N, Chen HH (2012) Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res 72:4616\u20134621","journal-title":"Cancer Res"},{"key":"1754_CR24","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1535-7163.MCT-12-0580","volume":"11","author":"ZD Liang","year":"2012","unstructured":"Liang ZD et al (2012) Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther 11:2483\u20132494","journal-title":"Mol Cancer Ther"},{"key":"1754_CR25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/bjc.1992.419","volume":"66","author":"SY Loh","year":"1992","unstructured":"Loh SY, Mistry P, Kelland LR, Abel G, Harrap KR (1992) Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine\/amine complexes. Br J Cancer 66:1109\u20131115","journal-title":"Br J Cancer"},{"key":"1754_CR26","doi-asserted-by":"crossref","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","volume":"8","author":"R Marullo","year":"2013","unstructured":"Marullo R et al (2013) Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS ONE 8:e81162","journal-title":"PLoS ONE"},{"key":"1754_CR27","first-page":"3630","volume":"46","author":"JR Masters","year":"1986","unstructured":"Masters JR et al (1986) Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 46:3630\u20133636","journal-title":"Cancer Res"},{"key":"1754_CR28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/bbrc.1994.2306","volume":"203","author":"H Masuda","year":"1994","unstructured":"Masuda H, Tanaka T, Takahama U (1994) Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203:1175\u20131180","journal-title":"Biochem Biophys Res Commun"},{"key":"1754_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/bjc.1993.322","volume":"68","author":"KJ Mellish","year":"1993","unstructured":"Mellish KJ, Kelland LR, Harrap KR (1993) In vitro drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer 68:240\u2013250","journal-title":"Br J Cancer"},{"key":"1754_CR30","volume-title":"Test No 117: Partition coefficient (n-octanol\/water); HPLC method","author":"Guidelines for the Testing of Chemicals","year":"2004","unstructured":"OECD Guidelines for the Testing of Chemicals (2004) Test No 117: Partition coefficient (n-octanol\/water); HPLC method. OECD Publishing, Paris"},{"key":"1754_CR31","first-page":"487","volume":"54","author":"J Oldenburg","year":"1994","unstructured":"Oldenburg J et al (1994) Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro. Cancer Res 54:487\u2013493","journal-title":"Cancer Res"},{"key":"1754_CR32","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1074\/jbc.M707568200","volume":"283","author":"N Pabla","year":"2008","unstructured":"Pabla N, Huang S, Mi Q-S, Daniel R, Dong Z (2008) ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 283:6572\u20136583","journal-title":"J Biol Chem"},{"key":"1754_CR33","unstructured":"Pliss E, Sen V, Tichonov I (2013) Nitroxyl radicals in chemical and biological processes. LAP Lambert AP, Saarbr\u00fccken (in Russian)"},{"key":"1754_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","volume":"33","author":"CA Rabik","year":"2007","unstructured":"Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33:9\u201323","journal-title":"Cancer Treat Rev"},{"key":"1754_CR35","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","volume":"52","author":"O Rixe","year":"1996","unstructured":"Rixe O et al (1996) Oxaliplatin, tetraplatin, cisplatin and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute\u2019s Anticancer Drug screen panel. Biochem Pharmacol 52:1855\u20131865","journal-title":"Biochem Pharmacol"},{"key":"1754_CR36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00280-005-0121-5","volume":"57","author":"G Samimi","year":"2006","unstructured":"Samimi G, Howell SB (2006) Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters. Cancer Chemother Pharmacol 57:781\u2013788","journal-title":"Cancer Chemother Pharmacol"},{"key":"1754_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0162-0134(96)00029-3","volume":"64","author":"VD Sen","year":"1996","unstructured":"Sen VD, Golubev VA, Volkova LM, Konovalova NP (1996) Synthesis and antitumor activity of platinum(II) complexes with trans-3,4-diamino-2,2,6,6-tetramethylpiperidine-1-oxyl. J Inorg Biochem 64:69\u201377","journal-title":"J Inorg Biochem"},{"key":"1754_CR38","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/BF02495168","volume":"49","author":"VD Sen","year":"2000","unstructured":"Sen VD et al (2000) Synthesis, structure, and biological activity of mixed-ligand platinum(II) complexes with aminonitroxides. Russ Chem Bull 49:1613\u20131619","journal-title":"Russ Chem Bull"},{"key":"1754_CR39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1023475319835","volume":"52","author":"VD Sen","year":"2003","unstructured":"Sen VD, Tkachev VV, Volkova LM, Goncharova SA, Raevskaya TA, Konovalova NP (2003) Synthesis, structure, and antitumor properties of platinum(IV) complexes with aminonitroxyl radicals. Russ Chem Bull 52:421\u2013426","journal-title":"Russ Chem Bull"},{"key":"1754_CR40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11172-006-0215-1","volume":"55","author":"VD Sen","year":"2006","unstructured":"Sen VD, Goluvev A, Lugovskaya NY, Sashenkova TE, Konovolova NP (2006) Synthesis and antitumor properties of new platinum(IV) complexes with aminonitroxyl radicals. Russ Chem Bull 55:62\u201365","journal-title":"Russ Chem Bull"},{"key":"1754_CR41","first-page":"385","volume-title":"Nitroxides: theory, experiment and applications","author":"VD Sen","year":"2012","unstructured":"Sen VD, Terentiev AA, Konovalova NP (2012) Platinum complexes with bioactive nitroxyl radicals: synthesis and antitumor properties. In: Kokorin AI (ed) Nitroxides: theory, experiment and applications. InTech, Rijeka, pp 385\u2013406"},{"key":"1754_CR42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<108::AID-JCP13>3.0.CO;2-4","volume":"183","author":"DW Shen","year":"2000","unstructured":"Shen DW, Goldenberg S, Pastan I, Gottesman MM (2000) Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J Cell Physiol 183:108\u2013116","journal-title":"J Cell Physiol"},{"key":"1754_CR43","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH (2003) Cisplatin: mode of action and molecular basis of resistance. Oncogene 22:7265\u20137279","journal-title":"Oncogene"},{"key":"1754_CR44","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1535-7163.1543.3.12","volume":"3","author":"IS Song","year":"2004","unstructured":"Song IS et al (2004) Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther 3:1543\u20131549","journal-title":"Mol Cancer Ther"},{"key":"1754_CR45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000421-198804000-00013","volume":"11","author":"DJ Stewart","year":"1988","unstructured":"Stewart DJ et al (1988) Platinum concentrations in human autopsy tumor samples. Am J Clin Oncol 11:152\u2013158","journal-title":"Am J Clin Oncol"},{"key":"1754_CR46","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/cncr.20898","volume":"103","author":"S Suy","year":"2005","unstructured":"Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U (2005) Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Cancer 103:1302\u20131313","journal-title":"Cancer"},{"key":"1754_CR47","first-page":"5707","volume":"53","author":"H Timmer-Bosscha","year":"1993","unstructured":"Timmer-Bosscha H et al (1993) Cis-diamminedichloroplatinum(II) resistance in vitro and in vivo in human embryonal carcinoma-cells. Cancer Res 53:5707\u20135713","journal-title":"Cancer Res"},{"key":"1754_CR48","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0277-5379(90)90133-E","volume":"26","author":"MC Walker","year":"1990","unstructured":"Walker MC, Povey S, Parrington JM, Riddle PN, Knuechel R, Masters JR (1990) Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines. Eur J Cancer 26:742\u2013747","journal-title":"Eur J Cancer"},{"key":"1754_CR49","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","volume":"39","author":"NJ Wheate","year":"2010","unstructured":"Wheate NJ, Walker S, Craig GE, Oun R (2010) The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans 39:8113\u20138127","journal-title":"Dalton Trans"},{"key":"1754_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","volume":"126","author":"CS Wilcox","year":"2010","unstructured":"Wilcox CS (2010) Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126:119\u2013145","journal-title":"Pharmacol Ther"},{"key":"1754_CR51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","volume":"334","author":"X Yao","year":"2007","unstructured":"Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115\u2013124","journal-title":"Am J Med Sci"},{"key":"1754_CR52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bcp.2006.10.003","volume":"73","author":"J Zisowsky","year":"2007","unstructured":"Zisowsky J et al (2007) Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. Biochem Pharmacol 73:298\u2013307","journal-title":"Biochem Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1754-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-016-1754-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1754-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1754-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T19:22:52Z","timestamp":1656703372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-016-1754-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,15]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1754"],"URL":"https:\/\/doi.org\/10.1007\/s00204-016-1754-3","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,15]]}}}